Search Filters

Search Results

Found 1 results

510(k) Data Aggregation

    K Number
    K170239
    Device Name
    Leica FL560
    Date Cleared
    2017-07-05

    (160 days)

    Product Code
    Regulation Number
    892.1600
    Reference & Predicate Devices
    Why did this record match?
    Reference Devices :

    K092374

    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    The Leica FL560 is a surgical microscope accessory used in viewing intra-operative blood flow in the cerebral vascular area.

    Device Description

    Similar to the predicate device (Leica FL800 ULT approved under K141136), the Leica FL560 is an accessory to the Leica Microsystems (LMS) Class I 510(k) exempt surgical operating microscope (SOM). The Leica FL560 utilizes the illumination light source, supplied as standard with the SOM to produce excitation light which is filtered using an illumination filter (also referred to as the excitation filter) within the 460 - 500nm wavelength. An observation filter is introduced into the observer light path within the optics carrier of the SOM to enable visualization of the resulting fluorescence emission comprising of the green, yellow and red spectrum in a spectral band above ~510nm.

    AI/ML Overview

    Here's a summary of the acceptance criteria and the study details for the Leica FL560, based on the provided text:

    1. Table of Acceptance Criteria and Reported Device Performance

    The document does not explicitly present acceptance criteria in a quantitative table format with specific thresholds. Instead, it describes acceptance as achieving "functional equivalence" to the predicate device (Leica FL800 ULT) in various aspects. The reported performance confirms this equivalence.

    AspectAcceptance Criteria (Implied)Reported Device Performance (Leica FL560)
    Electrical SafetyConformance to IEC 60601-1:2005 (basic safety and essential performance), IEC 60601-1-2:2007 (electromagnetic compatibility), and IEC 60601-1-6:2010-06 (general requirements for basic safety and essential performance - usability).Identical to predicate; both met all acceptance criteria.
    Bench Testing (Functional)Mechanical and functional requirements (design specifications) met. Optical performance (spectral transmission, sufficiency of pass-through illumination) verified. Mechanical integration verified. Labeling reviewed for completeness, understandability, and accuracy. Ability to produce excitation peak between 460-500 nm and observation peak above 510 nm verified.All tests met pre-established acceptance criteria. Verification of (technical) Intended Use to produce light transference for an excitation peak between 460 nm and 500 nm and an observation peak above 510 nm was achieved. Functionally equivalent ability to produce excitation and observation peaks for use in viewing fluorescence of fluorophores intraoperatively on a Leica surgical microscope platform, based on review of FL560 test results vs. historical experience with predicate FL800 and QC standards for FL800.
    BiocompatibilityNot patient contacting; only external surface is anodized aluminum, so ISO 10993 testing not applicable.Identical to predicate; not patient contacting, only external surface is anodized aluminum, so ISO 10993 testing is not applicable.
    Preclinical (Functional Equivalence for Blood Flow Visualization)Ability to enable viewing of intra-operative blood flow in the cerebrovascular area in a manner that is functionally equivalent to the predicate device FL800ULT. Visual clarity and ability to discern vascular structures. (Predefined test cases, pass/fail criteria, and independent scoring assessments).The testing confirmed that the Leica FL560 meets the Indications for Use and provides functionally equivalent flow visualization to FL800ULT. All individual evaluations of comparative images confirmed that the Leica FL560 enabled visualization of intra-operative blood flow and vessel architecture in the cerebrovascular area in a functionally equivalent manner to the predicate device Leica FL800 ULT (n=18 comparative reviews, 100% confirmation). The FL560 additionally enabled concurrent visualization of background anatomical structures.
    Human Factors / UsabilityUsability equivalent to Leica's prior experience with FL800. Key functions performable by 100% of users in both neurosurgeon and nurse/tech groups. Consistent visualization of test card fluorescence and fluorescein fluorescence in a phantom vascular model. (Pre-defined test cases and objective pass/fail criteria).Human factors testing confirmed that the FL560 usability was equivalent to Leica prior experience with FL800. Similar controls and interfaces enabled 100% of users in both groups to perform key functions. FL560 consistently visualized test card fluorescence and fluorescein fluorescence in a phantom vascular model.

    2. Sample Size Used for the Test Set and Data Provenance

    • Bench Testing: The document states this was a "one-arm study using only the subject device FL560 on microscope platform M530 OH6". The sample size for filters is mentioned as being tested (optically, mechanically, geometrically assessed), but specific numbers are not provided. The data provenance is internal design verification testing ("in-house").
    • Preclinical Testing:
      • Sample Size: "Six comparative image sets of the same cerebrovascular anatomy in either non-occluded (patent, native) or occluded (clipped) status and representative of neurosurgical procedures were visualized by both the FL560 and FL800ULT systems." This refers to the cases. The report also states "(n=18 comparative reviews, 100% confirmation)", which implies 3 observations per comparative image set (6 sets * 3 observations = 18 reviews).
      • Data Provenance: Prospective animal study conducted at the University of Mainz, Germany Institute of Neurosurgical Pathology, using a porcine model.
    • Human Factors Testing:
      • Sample Size: "15 users per group were assessed via observational analysis." There were two distinct user groups (neurosurgeons, nurses/techs), so a total of 30 users.
      • Data Provenance: Prospective study conducted at the University of Utah Department of Neurosurgery, using a simulated operating room and a cerebral vascular aneurysm phantom model.

    3. Number of Experts Used to Establish the Ground Truth for the Test Set and Qualifications of Those Experts

    • Preclinical Testing: "Testing was completed at the University of Mainz, Germany Institute of Neurosurgical Pathology by neurosurgeons and veterinarians". The specific number of each is not given, but multiple experts from each specialization were involved. Their qualifications are stated as "neurosurgeons and veterinarians".
    • Human Factors Testing: This study focused on usability and performance by the users themselves rather than establishing a diagnostic ground truth. The "experts" involved were the primary users: "neurosurgeons" and "nurses/techs". The number of each was 15. The study itself was designed in accordance with FDA guidance for human factors.

    4. Adjudication Method for the Test Set

    • Preclinical Testing: "independent scoring assessments that were predefined within the protocol." The specific adjudication method (e.g., 2+1, 3+1) is not detailed, but it implies multiple experts evaluating the images.
    • Human Factors Testing: This study involved "observational analysis" with "objective pass/fail criteria pre-defined within the protocol." It doesn't describe a separate adjudication process for ground truth establishment, but rather for performance of tasks by the users.

    5. If a Multi-Reader Multi-Case (MRMC) Comparative Effectiveness Study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance

    The studies described are not MRMC comparative effectiveness studies comparing human readers with and without AI assistance. The Leica FL560 is a surgical microscope accessory for viewing fluorescence, not an AI-powered diagnostic tool. The preclinical study was a comparative functional equivalence study between two devices (FL560 vs. FL800ULT) for blood flow visualization, and the human factors study assessed usability.

    6. If a Standalone (i.e., algorithm only without human-in-the-loop performance) was done

    This information is not applicable. The Leica FL560 is a hardware accessory for a surgical microscope. It does not contain an "algorithm" as typically referred to in AI/standalone performance studies. Its performance is entirely dependent on human-in-the-loop operation, as it provides visual information to the surgeon.

    7. The Type of Ground Truth Used

    • Preclinical Testing: The ground truth for evaluating blood flow visualization was established by the experts (neurosurgeons and veterinarians) observing the same cerebrovascular anatomy in known "non-occluded (patent, native) or occluded (clipped) status". This can be considered expert consensus with known physiological status/surgical intervention. The comparison was between the images produced by the two devices, FL560 vs FL800ULT, in relation to the actual blood flow patterns in the porcine model.
    • Human Factors Testing: The "ground truth" here related to the correct and safe operation of the device and the visibility of fluorescein. This was established by "pre-defined test cases and objective pass/fail criteria" and successful visualization in a "cerebral vascular aneurysm phantom model". This is effectively known device functionality and phantom model characteristics.

    8. The Sample Size for the Training Set

    This information is not applicable. The Leica FL560 is a medical device accessory, not an AI model requiring a training set.

    9. How the Ground Truth for the Training Set Was Established

    This information is not applicable, as there is no AI model or training set involved.

    Ask a Question

    Ask a specific question about this device

    Page 1 of 1